Remote Digital Care Effects in Adolescents With Type 1 Diabetes
- Conditions
- type1diabetes
- Interventions
- Other: TELEDUC-DIAB
- Registration Number
- NCT05421715
- Lead Sponsor
- University Hospital, Toulouse
- Brief Summary
Pilot study to evaluate effects of an experimental additional remote digital care (TELEDUC-DIAB) to adolescents with poorly controlled type 1 diabetes using digital monitoring platform and educative app
- Detailed Description
The use of digital technologies for the support and monitoring of diabetes have gradually become essential in recent years. The scientific literature reveals contrasting effects of digital and mobile technologies, both on adolescents with T1D (type 1 diabetes) and on their relatives. While the majority of studies have focused on connected devices for continuous blood glucose measurement, the specific effects of other tools, such as those of mobile patient therapeutic education applications or medical telemonitoring, are to this day still poorly documented or even unknown.
The study aim to describe the evolution of the glycemic control of adolescents with poorly controled type 1 diabetes during6 months individual TELEDUC-DIAB remote digital care in addition to their conventional follow-up.
The Medical-educational care (TELEDUC-DIAB) consist of:
* a personalized intensified remote care with a healthcare professional
* myDiabby platform: remote monitoring device integrating a data collection platform and systematized monitoring by alarms
* the Kidia application = a patient therapeutic education mobile application: developed by the Enfance, Adolescence et Diabète association, is a mobile application that patients can personalize (avatar,...) and help them understand and empower to deal with their diabetes.
This project offers original and innovative complementary monitoring: remotely, adapted to the specific needs of adolescents and aimed at improving glycemic control by developing self-efficacy and autonomy in adolescents in the management of diabetes.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Adolescent aged ≥12 and <18, with primary type 1 diabetes detected for at least 12 months, treated with multi-injection insulin or insulin pump
- Glycated hemoglobin greater than or equal to 8% for more than 3 months
- Use a continuous interstitial glucose recording system (CGM)
- Have at least one parent/guardian with a significant caregiver role in the management of the adolescent's diabetes (as determined by the investigator) participating in the study
- Have digital media compatible with the digital applications of the TELEDUC- DIAB (Mobile phone and computer)
• Other pathologies associated with diabetes which, according to the investigator, could interfere with glycemic control or the management of adolescent diabetes (examples: secondary diabetes, cystic fibrosis, Down syndrome; transplants, corticosteroid therapy, etc.)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description ALL ADOLESCENTS TELEDUC-DIAB For all adolescents, the proposed treatment consists, in addition to conventional care,an individual digital care and education(TELEDUC-DIAB)for 6 months using digital devices (myDiabby + Kidia).
- Primary Outcome Measures
Name Time Method Evolution of glycemic control hemoglobin (HbA1c) between inclusion and 6 months 6 months after inclusion Glycated hemoglobin (HbA1c) is currently the universally recognized biological marker for monitoring diabetes.
Glycated hemoglobin levels will be measured at inclusion, then 6 months after inclusion : a ratio will be deduced 6 months after inclusion with those two measures.
- Secondary Outcome Measures
Name Time Method Evolution of knowledge about diabetes and glycemic targets between inclusion and T6 months 6 months after inclusion an open question is asked to the participant each months of the study: "describe what glycated hemoglobin (hb1AC) is and the ideal ranges in which capillary blood glucose and hemoglobin measurements glycated must be located" Correctly answering these 3 key questions is associated with better glycemic control.
Each question will be scored by 0 (wrong answer or no answer), 0.5 (incomplete answer) and 1 (correct and complete answer).Evolution of adherence to TELEDUC-DIAB management between inclusion and 6 months 6 months after inclusion Non-adherence to the program will be determined if:
* \<80% of interstitial blood glucose is entered by the adolescent on the app over the last 14 days
* For adolescents with an insulin pump: average duration between 2 catheter changes greater than 3 days
* Monthly frequency of use of the TELEDUC-DIAB device :
* \< 4 monthly connections to the download platform
* \<1 monthly connection to the KIDIA application
* \<1 monthly telemonitoring connection with the professional
Trial Locations
- Locations (1)
University Hospital TOULOUSE
🇫🇷Toulouse, France